Understanding how flavivirus proteins suppress the immune response
Mechanistic Insights into flavivirus NS5-mediated STAT2 Suppression
This study is looking at how a specific protein from viruses like Dengue and Zika can trick our immune system, and it aims to find ways to help create better vaccines or treatments for these illnesses.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Riverside NIH-funded |
| Lab location | 1 site (Riverside, United States) |
| Project ID | NIH-11045058 on NIH RePORTER |
What this research studies
This research investigates how certain proteins from flaviviruses, like Dengue and Zika viruses, interfere with the body's immune response. The study focuses on the NS5 protein, which helps these viruses evade the antiviral defenses by degrading a key immune signaling protein called hSTAT2. By using advanced techniques such as structural analysis and biochemical assays, the researchers aim to uncover the mechanisms behind this suppression. The findings could lead to new strategies for developing vaccines or antiviral treatments against these viruses.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk of flavivirus infections, particularly those living in endemic regions.
Not a fit: Patients who are not at risk for flavivirus infections or those who have already been vaccinated against these viruses may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of effective vaccines or antiviral therapies for Dengue and Zika virus infections.
How similar studies have performed: Previous research has shown promising results in understanding viral mechanisms of immune evasion, suggesting that this approach could yield valuable insights.
Where this research is happening
Riverside, United States
- University of California Riverside — Riverside, United States (Active)
Researchers
- Principal investigator: Hai, Rong — University of California Riverside
- Study coordinator: Hai, Rong
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.